|
Volumn 17, Issue 1, 2002, Pages 19-28
|
Mitogen therapy for biological warfare/terrorist attacks and viral hemorrhagic fever control
|
Author keywords
Antibacterial vaccines; Antibiotic resistance; Antiviral vaccines; Biological warfare terrorist attacks; Ebola infection; Fraction IV; Ken Alibek; PHA; PWM; Viral hemorrhagic fevers
|
Indexed keywords
ANTHRAX VACCINE;
ANTIBIOTIC AGENT;
BOTULINUM TOXIN;
PLAGUE VACCINE;
Q FEVER VACCINE;
SARIN;
SMALLPOX VACCINE;
TULAREMIA VACCINE;
VIRUS VACCINE;
ANTHRAX;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
ARTICLE;
BACTERIAL INFECTION;
BIOLOGICAL WARFARE;
BRUCELLOSIS;
EBOLA VIRUS;
HUMAN;
IMMUNOMODULATION;
NONHUMAN;
PLAGUE;
PRIORITY JOURNAL;
Q FEVER;
SMALLPOX;
TERRORISM;
TULAREMIA;
TYPHUS;
VACCINATION;
VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS;
VIRUS ENCEPHALITIS;
VIRUS HEMORRHAGIC FEVER;
VIRUS INFECTION;
|
EID: 0036186522
PISSN: 10849785
EISSN: None
Source Type: Journal
DOI: 10.1089/10849780252824037 Document Type: Article |
Times cited : (1)
|
References (29)
|